NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

2.235 +0.005 (+0.22%)

Streaming Delayed Price Updated: 11:52 AM EDT, Apr 8, 2026 Add to My Watchlist

Price and Volume

Volume	385,928
Open	2.350
Bid (Size)	2.230 (2,600)
Ask (Size)	2.240 (2,100)
Prev. Close	2.230
Today's Range	2.180 - 2.350
52wk Range	1.580 - 3.840
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Labeling Feedback for Preservative-Free Ketamine Application

April 06, 2026

Via Investor Brand Network

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application

April 06, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

Performance

YTD	-14.7%	-14.7%
1 Month	+29.2%	+29.2%
3 Month	-6.5%	-6.5%
6 Month	-39.1%	-39.1%
1 Year	+23.5%	+23.5%

More News

AI-Powered “Depression Thermometer” to Aid Interventional Psychiatry Network via Strategic Partnership with Emobot for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

March 30, 2026

Via Get News

Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network

March 30, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)

March 28, 2026

Via ACCESS Newswire

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files 2025 Form 10-K And Highlights Operational Progress

March 24, 2026

Via Investor Brand Network

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

March 24, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST

March 21, 2026

Via ACCESS Newswire

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules March 24 Conference Call To Review 2025 Results And Clinical Progress

March 19, 2026

Via Investor Brand Network

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026

March 19, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Feedback On Bioequivalence For Ketamine Product

March 17, 2026

Via Investor Brand Network

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application

March 17, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting NDA Review For NRX-100

March 16, 2026

Via Investor Brand Network

NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

March 16, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST

March 14, 2026

Via ACCESS Newswire

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Appoints TMS, Neuroplasticity Researcher Joshua Brown MD, PhD, as Chief Medical Innovation Officer

March 11, 2026

Via Investor Brand Network

Effective One Day Treatment for Depression and PTSD Now Available at New Florida Clinic: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

March 10, 2026

Via Get News

BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Opens Palm Beach Clinic for Depression and PTSD Treatment

March 09, 2026

Via Investor Brand Network

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

March 09, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

New to The Street Broadcasts Tonight on Bloomberg Television at 6:30 PM EST - Shows 736, 737 and 738 Air Across the U.S., Latin America and MENA

March 07, 2026

Via ACCESS Newswire

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints Prof. Joshua C. Brown As Chief Medical Innovation Officer

March 02, 2026

Via Investor Brand Network

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

March 02, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

NRx Builds Momentum From FDA Progress To Strategic Expansion

February 27, 2026

Via NewMediaWire

NRx Builds Momentum From FDA Progress To Strategic Expansion

February 27, 2026

Via TheNewswire.com

FDA Meeting Indicates Path to New Drug Application with Real World Data and Broader Indication of NRX-100 (Ketamine) for Suicidal Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

February 17, 2026

Via Get News

Frequently Asked Questions

Is NRX Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, NRX Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does NRX Pharmaceuticals, Inc. - Common Stock trade on?

NRX Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock is NRXP on the Nasdaq Stock Market

What is the current price of NRX Pharmaceuticals, Inc. - Common Stock?

The current price of NRX Pharmaceuticals, Inc. - Common Stock is 2.235

When was NRX Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of NRX Pharmaceuticals, Inc. - Common Stock was at 04/08/26 11:52 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.